Royal Bank of Canada’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.25M | Buy |
|
|||||
|
2025
Q2 | $2.91M | Buy |
|
|||||
|
2025
Q1 | $2.92M | Sell |
|
|||||
|
2024
Q4 | $3.52M | Buy |
|
|||||
|
2024
Q3 | $2.05M | Buy |
|
|||||
|
2024
Q2 | $2.35M | Buy |
|
|||||
|
2024
Q1 | $671K | Sell |
|
|||||
|
2023
Q4 | $1.55M | Buy |
|
|||||
|
2023
Q3 | $324K | Sell |
|
|||||
|
2023
Q2 | $2.63M | Sell |
|
|||||
|
2023
Q1 | $3.14M | Sell |
|
|||||
|
2022
Q4 | $3.82M | Buy |
|
|||||
|
2022
Q3 | $688K | Buy |
|
|||||
|
2022
Q2 | $751K | Sell |
|
|||||
|
2022
Q1 | $1.09M | Sell |
|
|||||
|
2021
Q4 | $1.11M | Buy |
|
|||||
|
2021
Q3 | $629K | Buy |
|
|||||
|
2021
Q2 | $751K | Buy |
|
|||||
|
2021
Q1 | $43K | Buy |
|
|||||
|
2020
Q4 | $16K | Buy |
|
|||||
|
2020
Q3 | $15K | Buy |
|
|||||
|
2020
Q2 | $7K | Sell |
|
|||||
|
2020
Q1 | $6K | Sell |
|
|||||
|
2019
Q4 | $33K | Buy |
|
|||||
|
2019
Q3 | $8K | Hold |
|
|||||
|
2019
Q2 | $10K | Sell |
|
|||||
|
2019
Q1 | $15K | Sell |
|
|||||
|
2018
Q4 | $15K | Sell |
|
|||||
|
2018
Q3 | $83K | Sell |
|
|||||
|
2018
Q2 | $2.6M | Sell |
|
|||||
|
2018
Q1 | $1.09M | Sell |
|
|||||
|
2017
Q4 | $863K | Sell |
|
|||||
|
2017
Q3 | $430K | Buy |
|
|||||
|
2017
Q2 | $3K | Buy |
|
|||||
|
2017
Q1 | $1K | Buy |
|
|||||
|
2016
Q4 | $1K | Hold |
|
|||||
|
2016
Q3 | $1K | Sell |
|
|||||
|
2016
Q2 | $1K | Buy |
|
|||||
|
2016
Q1 | $0 | Sell |
|
|||||
|
2015
Q4 | $1K | Sell |
|
|||||
|
2015
Q3 | $22K | Sell |
|
|||||
|
2015
Q2 | $46K | Sell |
|
|||||
|
2015
Q1 | $94K | Buy |
|
|||||
|
2014
Q4 | $115K | Sell |
|
|||||
|
2014
Q3 | $223K | Buy |
|
|||||
|
2014
Q2 | $41K | Sell |
|
|||||
|
2014
Q1 | $52K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $20K | Buy |
|
|||||
|
2013
Q2 | $15K | Buy |
|